1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Benzenesulfonamides: new trials by email Literature Review of Benzenesulfonamides trials Research Report on Benzenesulfonamides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer Biopsy, Chemokine Modulation Therapy, Celecoxib - Triple -Negative Breast Cancer, Estrogen Receptor Negative | Early Phase 1 | Completed | Roswell Park Cancer Institute | 8 | 2019-01-09 | 2023-07-18 |
| Pre-Prostatectomy Celecoxib or Placebo Celecoxib, Placebo - Adenocarcinoma of the Prostate, Prostate Cancer | Phase 2 | Terminated | OHSU Knight Cancer Institute | 34 | 2001-05-01 | 2017-04-28 |
Prostatic Neoplasms (1) · Triple Negative Breast Neoplasms (1)
OHSU Knight Cancer Institute (1) · Roswell Park Cancer Institute (1)
United States (2)
Shipra Gandhi, MD (1) · Tomasz M Beer, MD (1)